- Obama hosting annual Easter Egg Roll
- Big Bang a big question for most Americans: Poll
- Jimmy Carter’s grandson: People have right to sport Confederate battle flag license plate
- Supreme Court issues no ruling on case challenging N.J. gun law
- Sharyl Attkisson: Media Matters ‘clearly targeted me’
- Sherpas consider boycott after Everest avalanche
- Democrat Rep. Stephen Lynch on Obamacare: ‘We will lose seats’ this November
- Syria to hold presidential election on June 3
- People will be safe at 118th Boston Marathon, Mayor Marty Walsh says
- Boy Scout, 12, killed by rolling tree during troop outing at Washington park
Sorting when early memory loss signals big threat
WASHINGTON (AP) - Doctors can’t tell if Leif Utoft Bollesen’s mild memory loss will remain an annoyance or worsen, but experimental checks of the Minnesota man’s aging brain may offer clues.
About 1 million people a year begin a mental slide called mild cognitive impairment, or MCI, with forgetfulness that’s somewhere between healthy aging and Alzheimer’s disease. Now this gray zone is undergoing an evolution, with growing study of techniques to help predict which MCI patients may be on a path to later dementia _ and who shouldn’t worry.
Many doctors aren’t waiting. A study published in the journal Neurology last week found 70 percent of neurologists say they prescribe Alzheimer’s medications to at least some of their MCI patients, hoping the drugs will slow their decline. That’s a startling number considering there’s no proof yet the drugs can do that even if doctors knew who’s most at risk.
Still, it’s becoming more and more clear that Alzheimer’s starts ravaging the brain at least a decade before memory problems appear. Thus stalling it may require treating the earliest symptoms, just as preventing a stroke begins with treating high blood pressure.
But to discover an early-stage therapy requires first discovering whose MCI really is pre-Alzheimer’s.
So when the National Institute on Aging and the nonprofit Alzheimer's Association proposed new guidelines for diagnosing both full-blown Alzheimer’s dementia and that confusing MCI, they went an extra step. The draft also offers a roadmap for researchers testing new technology to help separate out the different types of MCI.
On the list: experimental PET scans that check for abnormal brain buildup of an Alzheimer’s-linked gunk called beta-amyloid. Bollesen, 78, is getting that and other brain scans at the Mayo Clinic in a large study hunting for patterns that predict progression.
The retired teacher gets embarrassed by his main MCI symptom _ forgetting the names of longtime colleagues _ but says he doesn’t worry about getting worse.
“They haven’t told me what I can expect in the future. … I’ll think about it when they bring it up,” says Bollesen, 78, of Rochester, Minn. If he does worsen, he figures the researchers “may have ideas of things I could be doing to delay it.”
Here’s the rub: Those technologies are becoming more available for use outside of strict research studies. Already, doctors at specialized medical centers can use MRIs to measure shrinkage of a brain region called the hippocampus. They can give spinal taps to look for that gooey amyloid in cerebrospinal fluid.
Soon, even the full-brain amyloid scans will be more available, says Dr. David Bennett, director of Rush University Medical Center’s Alzheimer’s program in Chicago.
Patients “want to know what’s going to happen to them,” says Bennett, who tries to redirect patients already demanding those test, or anti-Alzheimer’s medications, into clinical trials.
Scientists haven’t proven when a bad test result really means brewing disease, or even if you can believe a bad test result. Those spinal fluid measurements, for example, can vary as much as 30 percent from one sophisticated laboratory to another, says Dr. Marilyn Albert of Johns Hopkins University.
“The last thing in the world you want to do is tell someone they’re destined to have Alzheimer’s dementia when they’re not,” cautions Albert, who co-authored the draft guidelines and doesn’t want doctors jumping the gun.
And just harboring amyloid alone doesn’t mean pending dementia, as autopsy studies suggest a quarter of elderly people who die without memory problems may harbor the buildup, adds Mayo’s Dr. Ron Petersen, who helped to first define MCI.
TWT Video Picks
Women losing coverage under Obamacare, too
- Tactical advantage: Russian military shows off impressive new gear
- USAID documents cite Hillary Clinton in chaos of Afghan aid
- Twitter blocks accounts critical of Turkish government
- Former Ranger breaks silence on Pat Tillman death: I may have killed him
- Scalia to students on high taxes: At a certain point, 'perhaps you should revolt'
- Special Forces' suicide rates hit record levels casualties of 'hard combat'
- Jimmy Carter's grandson: People have right to sport Confederate battle flag license plate
- Feds approve powdered alcohol; 'Palcohol' available later this year
- America is an oligarchy, not a democracy or republic, university study finds
- CURL: Shelly O first lady Michelle Obama comes in last
Top 10 handguns in the U.S.